NCT03982706 is a clinical trial in Prostate Cancer, sponsored by Rabin Medical Center.

Who is sponsoring NCT03982706?

NCT03982706 is sponsored by Rabin Medical Center.

What condition does NCT03982706 study?

NCT03982706 studies Prostate Cancer.

Is NCT03982706 still recruiting?

NCT03982706 is currently status unknown. Last updated 13 June 2019.

Last reviewed 2019-06-13 · How we verify

NCT03982706

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy

Status unknown Last updated 13 June 2019

What this trial tests

trial in Prostate Cancer in 1,000 participants. Status unknown.

Timeline

28 October 2015

Primary endpoint
6 June 2020

6 June 2020

Quick facts

Lead sponsor	Rabin Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	28 October 2015
Primary completion	6 June 2020
Estimated completion	6 June 2020

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

Rabin Medical Center

Who can join

Adults 18 to 90, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to determine whether focal-driven therapies for diagnosis and treatment of prostate cancer are preferable over current clinical methods. Different focal procedures will be examined, including magnetic resonance imaging (MRI)-target biopsy, and focal treatment as High Intensity Focused Ultrasound (HIFU), cryoablation and Nano-Knife.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Biomolecule-functionalized nanoformulations for prostate cancer theranostics.
Pranav, Laskar P, Jaggi M, Chauhan SC, et al · · 2023 · cited 20× · PMID 36368516 · DOI 10.1016/j.jare.2022.11.001
Focal therapy, time to join the multi-disciplinary team discussion?
Reddy D, Bedi N, Dudderidge T. · · 2020 · cited 2× · PMID 32676440 · DOI 10.21037/tau.2019.09.30

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other Rabin Medical Center trials

Trials by the same sponsor.

NCT06837909 — Transversus Abdominis Plane Block Versus Wound Infiltration for Pulmonary Function Preservation Following Laparoscopic L · NA · recruiting
NCT06951399 — Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07208240 — Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST T · Phase 1, PHASE2 · recruiting
NCT06931119 — Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients · Phase 1 · not yet recruiting
NCT06966427 — Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Inje · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03982706 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rabin Medical Center
Last refreshed: 13 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03982706.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing